Tuberculosis

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those affected. The classic symptoms of active TB are a chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically called consumption due to the weight loss. Infection of other organs can cause a wide range of symptoms.Tuberculosis …

Wikipedia

Publications

WHO: World Health Organization · 13 November 2024 English

vi, 20 p.

criteria and processes for the validation of tuberculosis elimination1Consultation report, Istanbul, Türkiye criteria and processes for the validation of tuberculosis elimination1 Development of metrics, criteria criteria and processes for the validation of tuberculosis elimination: consultation report, Istanbul, Türkiye criteria and processes for the validation of tuberculosis elimination: consultation report, Istanbul Abbreviations ACF active case finding TB tuberculosis TPT tuberculosis preventive treatment WGS whole genome


WHO: World Health Organization · 13 November 2024 English

[‎iv]‎, 18 p.

concentrating on human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C, the initiative has expanded Miltefosine 20 mg SDT LXE408 Amphotericin B SDF Tuberculosis Rifapentine 150 mg SDT All compounds in or shortly int/handle/10665/374270). 9. Paediatric drug optimization for tuberculosis: meeting report, October 2023. Geneva: World


WHO: World Health Organization · 12 November 2024 English

xxii, 219 p.

country (SDG 3.2). • End epidemics of HIV, tuberculosis, malaria, neglected tropical diseases and other


WHO: World Health Organization · 11 November 2024 English

vii, 66 p.

Parambir Gill (The Global Fund to Fight AIDS, Tuberculosis and Malaria [Global Fund], Switzerland), Ramy


WHO: World Health Organization · 8 November 2024 English

xxiv, 236 p.

Quality of care SatO2 Oxygen Saturation TBC Tuberculosis UN United Nations UNFPA United Nations Population


WHO: World Health Organization · 7 November 2024 English

vii, 16 p.

Nutrition STI Sexually Transmitted Infection TB Tuberculosis  TPP Target product profile TXA Tranexamic acid Isoniazid Tablet/dispersible 100 mg isoniazid xvii Tuberculosis (TB) exposure prophylaxis Newborns exposed possible after birth. xxii In settings where tuberculosis is highly endemic or in settings where there there is high risk of exposure to tuberculosis a single dose of BCG vaccine should be given to all infants


WHO: World Health Organization · 7 November 2024 English

vi, 17 p.

criteria and processes for the validation of tuberculosis elimination Consultation report, 13–14 June criteria and processes for the validation of tuberculosis elimination Consultation report, 13–14 June criteria and processes for the validation of tuberculosis elimination: consultation report, 13-14 June criteria and processes for the validation of tuberculosis elimination: consultation report, 13-14 June Considerations for measuring transmission of M. tuberculosis ...........................................


WHO: World Health Organization · 7 November 2024 English

ix, 151 p.

examples only. NCD: noncommunicable disease; TB: tuberculosis.11 Participation of persons with disabilities


WHO: World Health Organization · 7 November 2024 English

vii, 43 p.

• Many frontline health workers have latent tuberculosis or suffer from chronic lower back pain, depression occupational infections and diseases, such as HIV, tuberculosis, and hepatitis B and C; – utilizes appropriate


WHO: World Health Organization · 7 October 2024 English

ix, 57 p.

....................................... 25 Tuberculosis ........................................... infectious diseases epidemics, including HIV and tuberculosis (TB) [27–29]. Moreover, over the next 10 years in-hospital mortality in patients with COVID-19 Tuberculosis Seventeen studies included in this systematic systematic review reported data on tuberculosis (TB) among the participants. The pooled TB prevalence was 2% 69) (Figure 16). Fig. 16. Forest plots of tuberculosis effect on in-hospital mortality in patients


View more